IGFBP-5 induces epithelial and fibroblast responses consistent with the fibrotic response

Biochemical Society Transactions

Volumn 37, Issue 4, 2009, Pages 882-885

  Sureshbabu, Angara ^a   Okajima, Hiroshi ^b   Yamanaka, Daisuke ^b   Shastri, Surya ^a   Tonner, Elizabeth ^a   Rae, Colin ^a   Szymanowska, Malgorzata ^a   Shand, John H ^a   Takahashi, Shin Ichiro ^b   Beattle, James ^c   Allan, Gordon J ^a   Flint, David J ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Epithelial mesenchymal transition; Fibrosis; Insulin like growth factor; Senescence; Tissue injury; Transforming growth factor (TGF )

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; BINDING AFFINITY; CELL ACTIVATION; CELL AGING; CELL DAMAGE; CELL LOSS; CELL MIGRATION; CELL TRANSFORMATION; CONFERENCE PAPER; EPITHELIUM CELL; FIBROBLAST; FIBROSIS; HUMAN; INFLAMMATION; LIVER FIBROSIS; LUNG FIBROSIS; MESENCHYME CELL; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SKIN FIBROSIS; ANIMAL; EPITHELIUM; MESODERM; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; EPITHELIUM; FIBROBLASTS; FIBROSIS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MESODERM; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70349332328     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0370882     Document Type: Conference Paper

References (39)

1. Gross, T.J. and Hunninghake, G.W. (2001) Idiopathic pulmonary fibrosis. N. Engl. J. Med. 345, 517-525
2. Highland, K.B. and Silver, R.M. (2005) New developments in scleroderma interstitial lung disease. Curr. Opin. Rheumatol. 17, 737-745
3. Takehara, K. (2003) Hypothesis: pathogenesis of systemic sclerosis. J. Rheumatol. 30, 755-759
4. Leask, A. and Abraham, D.J. (2004) TGF-β signaling and the fibrotic response. FASEB J. 18, 816-827
5. Selman, M. and Pardo, A. (2006) Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc. Am. Thorac. Soc. 3, 364-372
6. Hayflick, L. and Moorhead, P.S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621
7. Pagano, P.J. and Gutterman, D.D. (2007) The adventitia: the outs and ins of vascular disease. Cardiovasc. Res. 75, 636-639
8. Kim, K.S., Seu, Y.B., Baek, S.H., Kim, M.J., Kim, K.J., Kim, J.H. and Kim, J.R. (2007) Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol. Biol. Cell 18, 4543-4552
9. Scotton, C.J. and Chambers, R.C. (2007) Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132, 1311-1321
10. Jenkins, R.G., Su, X., Su, G., Scotton, C.J., Camerer, E., Laurent, G.J., Davis, G.E., Chambers, R.C., Matthay, M.A. and Sheppard, D. (2006) Ligation of protease-activated receptor 1 enhances αvβ6 integrin-dependent TGF-β activation and promotes acute lung injury. J. Clin. Invest. 116, 1606-1614
11. Beattie, J., Allan, G.J., Lochrie, J.D. and Flint, D.J. (2006) Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem. J. 395, 1-19
12. Feghali, C.A. and Wright, T.M. (1999) Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis. Arthritis Rheum. 42, 1451-1457
13. Pilewski, J.M., Liu, L., Henry, A.C., Knauer, A.V. and Feghali-Bostwick, C.A. (2005) Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am. J. Pathol. 166, 399-407
14. Yasuoka, H., Jukic, D.M., Zhou, Z., Choi, A.M. and Feghali-Bostwick, C.A. (2006) Insulin-like growth factor binding protein 5 induces skin fibrosis: a novel murine model for dermal fibrosis. Arthritis Rheum. 54, 3001-3010
15. Yasuoka, H., Zhou, Z., Pilewski, J.M., Oury, T.D., Choi, A.M. and Feghali-Bostwick, C.A. (2006) Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration. Am. J. Pathol. 169, 1633-1642
16. Flint, D.J., Tonner, E. and Allan, G.J. (2000) Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in the mammary gland. J. Mammary Gland Biol. Neoplasia 5, 65-73
17. Guenette, R.S. and Tenniswood, M. (1994) The role of growth factors in the suppression of active cell death in the prostate: an hypothesis. Biochem. Cell Biol. 72, 553-559
18. Tonner, E., Barber, M.C., Allan, G.J., Beattie, J., Webster, J., Whitelaw, C.B. and Flint, D.J. (2002) Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development 129, 4547-4557
19. O'Donnell, S.L., Frederick, T.J., Krady, J.K., Vannucci, S.J. and Wood, T.L. (2002) IGF-I and microglia/macrophage proliferation in the ischemic mouse brain. Glia 39, 85-97
20. Sorrell, A.M., Shand, J.H., Tonner, E., Gamberoni, M., Accorsi, P.A., Beattie, J., Allan, G.J. and Flint, D.J. (2006) Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin. J. Biol. Chem. 281, 10883-10889
21. Xu, J., Lamouille, S. and Derynck, R. (2009) TGF-β-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172
22. Wu, Y. and Zhou, B.P. (2008) New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim. Biophys. Sin. 40, 643-650
23. Garcia, C.K., Wright, W.E. and Shay, J.W. (2007) Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res. 35, 7406-7416
24. Yoon, I.K., Kim, H.K., Kim, Y.K., Song, I.H., Kim, W., Kim, S., Baek, S.H., Kim, J.H. and Kim, J.R. (2004) Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology. Exp. Gerontol. 39, 1369-1378
25. Hampel, B., Fortschegger, K., Ressler, S., Chang, M.W., Unterluggauer, H., Breitwieser, A., Sommergruber, W., Fitzky, B., Lepperdinger, G., Jansen-Durr, P. et al. (2006) Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescence. Exp. Gerontol. 41, 474-481
26. Yasuoka, H., Yamaguchi, Y. and Feghali-Bostwick, C.A. (2009) The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. Am. J. Respir. Cell Mol. Biol., doi:10.1165/rcmb.2008-0211OC
27. Andress, D.L. (1998) Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. Am. J. Physiol. 274, E744-E750
28. Schedlich, L.J., Young, T.F., Firth, S.M. and Baxter, R.C. (1998) Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J. Biol. Chem. 273, 18347-18352
29. Mohan, S., Thompson, G.R., Amaar, Y.G., Hathaway, G., Tschesche, H. and Baylink, D.J. (2002) ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Biochemistry 41, 15394-15403
30. Mohan, S. and Baylink, D.J. (2002) IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J. Endocrinol. 175, 19-31
31. Amaar, Y.G., Thompson, G.R., Linkhart, T.A., Chen, S.T., Baylink, D.J. and Mohan, S. (2002) Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J. Biol. Chem. 277, 12053-12060
32. Jurgeit, A., Berlato, C., Obrist, P., Ploner, C., Massoner, P., Schmolzer, J., Haffner, M.C., Klocker, H., Huber, L.A., Geley, S. and Doppler, W. (2007) Insulin-like growth factor-binding protein-5 enters vesicular structures but not the nucleus. Traffic 8, 1815-1828
33. Allan, G.J., Beattie, J. and Flint, D.J. (2008) Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5. J. Endocrinol. 199, 155-164
34. Inoki, I., Shiomi, T., Hashimoto, G., Enomoto, H., Nakamura, H., Makino, K., Ikeda, E., Takata, S., Kobayashi, K. and Okada, Y. (2002) Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J. 16, 219-221
35. Abreu, J.G., Ketpura, N.I., Reversade, B. and De Robertis, E.M. (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat. Cell Biol. 4, 599-604
36. Nguyen, T.Q. and Goldschmeding, R. (2008) Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? Pharm. Res. 25, 2416-2426
37. Nam, T.J., Busby, Jr, W.H., Rees, C. and Clemmons, D.R. (2000) Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Endocrinology 141, 1100-1106
38. Clemmons, D.R., Busby, W.H., Arai, T., Nam, T.J., Clarke, J.B., Jones, J.I. and Ankrapp, D.K. (1995) Role of insulin-like growth factor binding proteins in the control of IGF actions. Prog. Growth Factor Res. 6, 357-366
39. Allan, G.J., Flint, D.J. and Patel, K. (2001) Insulin-like growth factor axis during embryonic development. Reproduction 122, 31-39